Cjc-1295 with Dac

CJC 1295 DAC, a long acting GHRH polypeptide 2mg/vial

Cas No. 863288-34-0
Appearance: Peptides Lyophilized Powder
Purity: 99% min
Product Usage:
CJC 1295 DAC, a long acting GHRH polypeptide. DAC conjugated CJC 1295, makes this GHRH have a half life of more than a week (approx. 8 days). GHRH is released in pulses in the body which alternate with corresponding pulses of somatostatin. Ghrelin, released from the gut which circulates and acts as a hunger hormone, has synergistic activity in the body with GHRH and also suppresses somatostatin to make way for the GHRH pulse. Studies shows that combining GHRP with CJC 1295 DAC.
 
CJC-1295 Peptide Profile

 CJC-1295 is an injectable peptide used to increase GH production. This peptide is a growt hormone releasing hormone (GHRH) mimetic, or analog. That is to say, it works in the same way as GHRH, and may be referred to as being a GHRH.
The principal use of CJC-1295 is to provide increased GH levels, which also results in increased IG F-1 levels. An increase in these levels can aid fat loss and in some instances can aid muscle gain as well. Generally, a product in the GHRH category, including CJC-1295, is chosen as an alternate to using GH, and only rarely is combined with GH.
The other principal GHRH product is Mod GRF 1-29, which in most instances I recommend over CJC-1295. The products differ in their duration of action. Mod GRF has an approximately-ideal short duration of action allowing pulsatile dosing, whereas CJC-1295 has an extended duration of action which prevents such dosing.
It's important to avoid confusing CJC-1295 with "CJC-1295 w/o DAC." The latter is not CJC-1295, but rather is misnamed Mod GRF. When a peptide doesn't have DAC, it's not CJC-1295.
CJC 1295 is sometimes marketed as "CJC-1295 with DAC." This simply is CJC-1295.

When to use CJC-1295

This product is most suited to instances where an individual wishes to inject infrequently and is seeking substantive support for GH production rather than a maximum or near-maximum increase. This is because the flat blood levels it provides do not match up well with pulsatile dosing, which is needed for greatest effect. The steady levels can provide very good support for natural GH pulses, however.
Relatively rarely, adverse side effects associated with excessive GH use, such as pain from nerve compression (such as carpal tunnel pain), excessive water retention, or reduced insulin sensitivity can occur from CJC-1295 use. The cause is stimulation of a greater amount of GH production than is suitable for the individual case. The solution is to discontinue use until the problem is resolved, and to reduce dosage when resuming use.
For ongoing support of GH production, at doses recommended below, CJC-1295 does not need to be cycled.

How to use CJC-1295

CJC 1295 is typically provided in vials containing 2 or 5 mg of lyophylized powder, though the amount can vary. The contents should be reconstituted by adding a convenient amount of sterile or bacteriostatic water. If for example 2 mL is chosen and the dosing of the vial is 2 mg, the resulting solution then has a concentration of 1 mg/mL, or 1000 mcg/mL.
At time of dosing, an insulin syringe is used to draw and then inject the desired amount. In the above example, a 1000 mcg dose would require a volume of 1 mL, or "100 IU" as marked on an insulin syringe.
Injection may be subcutaneous, intramuscular, or intravenous according to personal preference. If desired, peptide solutions from other vials, such as a vial of a GHRP product, may also be drawn into the same syringe, if there is room. This reduces the total number of injections required.
When recommending CJC 1295, I ordinarily recommend a dosage of 1000 mcg at a time, twice per week.

Combined use of CJC-1295 and a GHRP

As with Mod GRF, CJC-1295 use can be combined with use of GHRP, but if using a GHRP, for superior results I recommend combining Mod GRF with it rather than CJC-1295.
The most important reason for this is observed results. The principal cause of it is that the DAC modification results in relatively lower levels of free peptide. In and of itself, this would be a bad thing, but it's counterbalanced by the lower levels being sustained. However, if creating peaks with a GHRP, it's more efficient to have higher levels of free GHRH peptide in, so to speak, "lock step" with those peaks. Mod GRF does this, while CJC-1925 does not.If choosing CJC-1295 anyway to stack with a GHRP, dosing of the CJC-1295 remains as recommended above, while GHRP dosing will be typically 100 mcg at a time, or 50 mcg at a time if using hexarelin.

	Product  name	Specification
T-A001	MGF	2mg
T-A002	PEG MGF	2mg
T-A003	CJC-1295 with DAC	2mg
T-A004	CJC-1295 without DAC	2mg
T-A005	PT-141	10mg
T-A006	MT-1	10mg
T-A007	MT-2	10mg
T-A008	GHRP-2	5mg
T-A008	GHRP-2	10mg
T-A009	GHRP-6	5mg
T-A009	GHRP-6	10mg
T-A010	Ipamorelin	2mg
T-A011	Hexarelin	2mg
T-A012	Sermorelin	2mg
T-A013	Oxytocin	2mg
T-A014	TB500	2mg
T-A015	pentadecapeptide BPC 157	2mg
T-A017	Triptorelin	2mg
T-A018	Tesamorelin	2mg
T-A020	Gonadorelin	2mg
T-A020	Gonadorelin	10mg
T-A021	DSIP	2mg
T-A022	Selank	5mg